Company news
Bruker Corporation (NASDAQ:BRKR) news
Every Bruker Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories
August 11, 2026
Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development
August 10, 2026
Bruker Reports Second Quarter 2026 Financial Results
August 4, 2026
Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast
July 24, 2026
Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood
July 15, 2026
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026
June 4, 2026
Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry
June 2, 2026
Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and ...
June 1, 2026
Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI
May 26, 2026
Bruker : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)
May 7, 2026
Opportunity Insights for the $1.1 Billion Preclinical Imaging Industry, 2026 - Bruker Corp., Cubresa, and Siemens Healthineers Lead
May 6, 2026
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast
April 24, 2026
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights ...
April 17, 2026
Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management
April 17, 2026
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026
April 17, 2026
Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026
April 13, 2026
Bruker : 2025 Annual Report of 2025
April 10, 2026
Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research
April 7, 2026
Bruker Announces Appointment of Thierry Bernard to its Board of Directors
April 1, 2026
PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge
March 31, 2026
Bruker : Showcases Analytical and Automation Innovations for Applied, Biopharma, Industrial and Academic Markets at Analytica 2026
March 23, 2026
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
February 25, 2026
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
February 24, 2026
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
February 23, 2026
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
February 23, 2026
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
February 9, 2026
Bruker Announces Quarterly Preferred Stock Dividend
February 5, 2026
Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast
February 5, 2026
Arch Biopartners Announces Appointment of Dr. Patrick Vink as Chairman of the Board
January 16, 2026
Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors fo...
January 9, 2026
Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets
January 8, 2026
Bruker Corporation to Present at the J.P. Morgan Healthcare Conference
January 7, 2026
RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)
December 22, 2025
AbCellera and Bruker Reach Global Settlement of Patent Litigation
December 18, 2025
Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Ins...
December 10, 2025
Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026
December 8, 2025
Indaba Capital Announces Sale of AST Revolution to Bruker
November 24, 2025
Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend
November 4, 2025
Bruker Reports Third Quarter 2025 Financial Results
November 3, 2025
Bruker Announces Date and Time of Third Quarter 2025 Earnings Release and Webcast
October 22, 2025
Bruker Announces Orders for NIH- and NSF-Funded NMR Systems from New York Structural Biology Center, University of Delaware and Northwest...
October 3, 2025
Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock
September 3, 2025
Bruker Announces Public Offering of $600 Million of Mandatory Convertible Preferred Stock
September 2, 2025
Bruker Announces Quarterly Dividend
August 12, 2025
Bruker Secures Multi-Year Contracts for Explosives and Chemical Trace Detection in Aviation and Defense Sectors
August 6, 2025
Bruker Reports Second Quarter 2025 Financial Results
August 4, 2025
Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025
July 21, 2025
Bruker Experiences Growth in Semiconductor Advanced Packaging Market Fueled by AI Demands
June 24, 2025
Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics
June 3, 2025